Heart Transplantation
📧 Sign up to get email alerts when something new happens for Heart Transplantation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2018-05-30Clinical Trial Update: Percutaneous Coronary Intervention in Patients witH OrthotoPic hEart Transplantation: the PCI-HOPE a Multicenter Study.
Clinical trial update on a multicenter study evaluating percutaneous coronary intervention in patients following orthotopic heart transplant…
-
FDA approval · 2018-05-24FDA Approved: PROGRAF — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for Prograf (tacrolimus) from Astellas Pharma US, Inc. to update its labeling and indications.
-
CLINICAL_TRIALS research · 2018-04-24Clinical Trial Update: Exercise-based Cardiac Rehabilitation Program on Hospitalized Heart Failure Patients Submitted to Cardiac Transplantation [NA]
An update on a clinical trial evaluating an exercise-based cardiac rehabilitation program for hospitalized heart failure patients who are ca…
-
CLINICAL_TRIALS research · 2018-04-11Clinical Trial Update: Autonomic Cardiovascular Control After Heart Transplantation
A clinical trial update for autonomic cardiovascular control after heart transplantation, sponsored by Oslo University Hospital; the current…
-
FDA approval · 2017-12-18FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for CELLCEPT (MYCOPHENOLATE MOFETIL) submitted by Genentech, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: Efficacy Study of Everolimus on Renal Function in Heart Transplant Recipients With Established Chronic Renal Failure [Phase 4]
Phase 4 study assessing the efficacy of Everolimus on renal function in heart transplant recipients with established chronic renal failure h…
-
CLINICAL_TRIALS trial_result · 2017-04-20Clinical Trial Update: Alloantibodies in Pediatric Heart Transplantation
A NIH-sponsored trial evaluating alloantibodies in pediatric heart transplantation was terminated, with results posted in 2017.
-
FDA approval · 2017-03-31FDA Approved: MYCOPHENOLATE MOFETIL — Original Application (Mylan Institutional LLC)
The FDA approved the original application for mycophenolate mofetil from Mylan Institutional LLC. It is indicated to prevent organ transplan…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Heart Transplant Recipients [Phase 3]
A Phase 3 clinical trial evaluated the efficacy and safety of enteric-coated mycophenolate sodium in heart transplant recipients; the study …
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: A Study of Safety, Tolerability & Efficacy of Certican in de Novo Heart Transplant (Tx) Patients [Phase 3]
Phase 3 trial evaluating safety, tolerability, and efficacy of Certican in de novo heart transplantation patients has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: Renal Safety of Everolimus in Addition to Cyclosporine Microemulsion in Cardiac Transplant Recipients. [Phase 3]
Phase 3 trial evaluating renal safety of adding everolimus to cyclosporine in heart transplant recipients has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: Everolimus Versus Mycophenolate Mofetil in Combination With Reduced Dose Cyclosporine Microemulsion in Maintenance Heart Transplant Recipients [Phase 4]
A Phase 4 trial comparing everolimus versus mycophenolate mofetil, both with reduced-dose cyclosporine microemulsion, as maintenance therapy…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Heart Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Heart Transplant Recipients [Phase 4]
Phase 4 trial in heart transplant recipients evaluating CellCept (mycophenolate mofetil) with Rapamune (sirolimus) was terminated.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of Daclizumab (Zenapax) in Combination With Mycophenolate Mofetil (CellCept) and Sirolimus in Prevention of Acute Rejection in Heart Transplant Participants [Phase 4]
Phase 4 clinical trial assessing daclizumab with mycophenolate mofetil and sirolimus to prevent acute rejection in heart transplant recipien…
-
CLINICAL_TRIALS research · 2016-10-19Clinical Trial Update: Satisfaction Degree in a Nurse Educational Program to Heart Transplant Patient
A clinical trial update evaluating patient satisfaction with a nurse educational program for heart transplant recipients.
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation [Phase 2, Phase 3]
A Phase 2/3 trial comparing zoledronic acid to alendronate for prevention of bone loss after organ transplantation has completed with result…
-
CLINICAL_TRIALS research · 2016-08-23Clinical Trial Update: Impact of mHealth in Heart Transplant Management [NA]
A clinical trial update examining the impact of mobile health (mHealth) tools on heart transplant management.
-
CLINICAL_TRIALS withdrawal · 2016-07-15Clinical Trial Update: Brachial Artery t-PA Release in Heart Transplant Recipients [NA]
A clinical trial evaluating brachial artery tissue plasminogen activator release in heart transplant recipients has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Thymic Tolerance in Pediatric Heart Transplantation [Phase 2]
A Phase 2 clinical trial evaluating thymic tolerance in pediatric heart transplantation has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-06-13Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Zenapax in Combination With CellCept, Cyclosporine, and Corticosteroids in Patients Undergoing Cardiac Transplantation [Phase 4]
A Phase 4 clinical trial assessing the efficacy and safety of Zenapax in combination with CellCept, cyclosporine, and corticosteroids in hea…
-
CLINICAL_TRIALS trial_result · 2016-05-25Clinical Trial Update: Pharmacokinetics of Mmf and Valganciclovir [Phase 4]
Phase 4 pharmacokinetic study of mycophenolate mofetil and valganciclovir in kidney and heart transplant recipients has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-15Clinical Trial Update: Study to Ascertain if Prolonged Release Tacrolimus (FK506E - MR4) is Safe and Effective When Used in the Long Term and in Combination With Other Immunosuppressive Drugs in Patients Who Have Received a Transplant [Phase 3]
Phase 3 trial evaluating long-term safety and efficacy of prolonged-release tacrolimus (FK506E-MR4) in transplant recipients when used with …
-
CLINICAL_TRIALS trial_result · 2016-01-01Clinical Trial Update: Noninvasive Methods to Monitor Graft Survival in Heart Transplant Patients
A completed clinical trial from NIAID evaluating noninvasive methods to monitor graft survival in heart transplant patients.
-
FDA approval · 2015-12-15FDA Approved: TACROLIMUS — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for tacrolimus submitted by Mylan Pharmaceuticals Inc.
-
FDA approval · 2015-11-13FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for mycophenolate mofetil submitted by Teva Pharmaceuticals USA, Inc., updating the drug's label…